Term ends Feb 19, 2036 · High confidence
20-year base term ends Feb 19, 2036
Held by Create Medicines, Inc.
Filed Apr 7, 2022 as application 17/715,710 · Granted Mar 5, 2024
Base term, 20 years from filing
Today
2016
2036
Clock starts
Feb 19, 2016
Feb 19, 2016
Term ends
Feb 19, 2036
Feb 19, 2036
Granted
Mar 5, 2024
Mar 5, 2024
base term
Updated Nov 15, 2026 · includes USPTO assignment & status data published Nov 15, 2026 and grant & fee data published Nov 10, 2026 (weekly) · how we know
None
Term adjustment
No prosecution delay on this record.
No effect
Terminal disclaimer
Resolved from the filed document, referencing US 11,517,589, US 11,918,605, to Feb 19, 2036. The term already ends on or before that date, so the cap shortened nothing.
0 of 2
Maintenance fees paid
Two maintenance fees can end this term early, the ones due 3.5 and 7.5 years from grant; the third one's grace period runs past the term end. This counts the ones the record shows paid.
7
Family applications on record here
Applications sharing this one's continuity chain whose file history this site holds. The family may have others.
This patent's term is its 20-year base term, with no adjustment for prosecution delay. A terminal disclaimer is resolved from the filed document, and it ends no earlier than this term, so it shortens nothing. 0 of 2 maintenance fees are paid so far. Confidence: High. from the record
How we calculated this date
One row per rule, each showing its own input and what it did to the date. A step we could not verify says so instead of resolving itself.
| Step | Input | Date after this step | Confidence |
|---|---|---|---|
| Base term, 20 years from filing | Clock starts Feb 19, 2016, when application 15/048,922, the earliest non-provisional in its chain, was filed (this one was filed Apr 7, 2022) | Feb 19, 2036 | High confidence |
| Continuity chain | Every parent in the chain resolved | no change | High confidence |
| Patent term adjustment | None on file | no change | High confidence |
| Terminal disclaimer cap | Disclaimer resolved from the filed document (refs US 11,517,589, US 11,918,605) | resolves to Feb 19, 2036, no earlier than this term, so no change | High confidence |
| Patent term extension | None on file | no change | High confidence |
| Fee events | 0 of 2 maintenance fees paid | In force | High confidence |
| Computed term end | The steps above, in order | Feb 19, 2036 | High confidence |
This family
| Application 15/048,922 | Abandoned not computed | not computed |
| Application 17/227,193 | Abandoned not computed | not computed |
| Application 17/559,967 | Abandoned not computed | not computed |
| US 11,918,604 | this patent Feb 2036 | Feb 2036 |
| US 11,517,589 | In force Feb 2036 | Feb 2036 |
| US 11,918,605 | In force Feb 2036 | Feb 2036 |
| Application 18/420,382 | Pending not computed | not computed |
The applications whose file history this site holds. The family may have others.
Assignments
Assignment documents as recorded at the USPTO, oldest first, with the reel and frame each was recorded at. A recorded assignment is a filed document, not a statement of current ownership, and the absence of a later one is not evidence that the last one still stands.
| Recorded | Assignor | Assignee | Conveyance |
|---|---|---|---|
| Apr 22, 2022 Reel 59683, frame 351 | Wagner, Samuel C.; Ichim, Thomas E.; Szymanski, Julia S.; Kesari, Santosh; Patel, Amit; Minev, Boris | Batu Biologics, Inc. | Assignment of Assignor's Interest |
| Apr 22, 2022 Reel 59684, frame 247 | Batu Biologics, Inc. | Myeloid Therapeutics, Inc. | Assignment of Assignor's Interest |
| Apr 13, 2026 Reel 75384, frame 783 | Myeloid Therapeutics, Inc. | Create Medicines, Inc. | Change of Name |
Sources
Google Patents · The patent document at USPTO · Assignment records at USPTO
USPTO account required: This application in Patent Center · USPTO's maintenance fee lookup
Maintenance fee events come from USPTO's own fee records. Its fee lookup asks for the patent number and the application number.
Free plan: 3 watched companies. Pro: unlimited.
Alerts on its grants, lapses and transfers.
What's changing
Feb 2036
Term ends Feb 19, 2036. Maintenance fees still fall due before then
Terminal disclaimer
A terminal disclaimer resolved from the filed document, referencing US 11,517,589, US 11,918,605, ends no earlier than this term, so it caps nothing.
Citations
6
later US patents cite this one
Fewer than half of the utility patents granted in 2024 in our data have been cited yet, so we show the count and do not rank on it.
How we rank
Every date shows its work: the base term, any term adjustment or extension, any disclaimer cap, and the maintenance fee record, each with a confidence tier. How this record was built
Computed patent terms end on the dates shown. Related patents and pending applications may cover overlapping subject matter.
In force means the term is running and no lapse is on record. It is not a finding that the patent is valid.